NCT05993910Recruiting
Prospective Hyperthermia Database in Cancer Patients (HT Register)
Prospektive Hyperthermie-Datenbank Bei Krebspatienten (HTRegister)
Source: ClinicalTrials.gov · Last updated 15 Aug 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This monocentric study registry records all cancer patients at the Charité which are treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer patients in the general application and to obtain an accurate risk-benefit balance After confinement in this database are the patients prospectively in order to complications, disease status and survival status tracked. Furthermore there is the possibility in the course of this study to an optional take part in translational accompanying research with the aim of prognostic factors for response to hyperthermia treatment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 3 Aug 2023
- Start date
- 1 Nov 2014
- Primary completion date
- 31 Oct 2028
- Lead sponsor
- Pirus Ghadjar
- Diseases
- Childhood cancers
- NCT number
- NCT05993910
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Nov 2014 to the primary completion date, 31 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Exclusion criteria for the hyperthermia (such as hip prosthesis in the therapeutic area, metal implants/marker, patients with cardiac pacemakers)
- mental disease, what the proper study participation does not allow.
Who the study is looking for
- Contrazeption with female patients at the capable of bearing children age
- Written agreement is present (DvH, ICH-GCP)
- Patients, who participate at the same time in a interventional study, can nevertheless in this register study participate if this none Exclusion criterion for the interventional study represents.
- With children must the treatment with one of the GPOH agreed Pattern take place
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinic for Radio - Oncology and Radiotherapy Coordinator of this site? Confirm its status | Berlin | Germany | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.